UGC CARE norms ugc approved journal norms IJRTI Research Journal

WhatsApp
Click Here

International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 7

Issue Published : 75

Article Submitted : 4303

Article Published : 2432

Total Authors : 6372

Total Reviewer : 533

Total Countries : 46

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: A Validated Rp-Hplc Method for Tablets Containing Amlodipine Besylate and Telmisartan Hcl as Active Pharmaceutical Ingredient.
Authors Name: Shaila Sumaiya , Anjali Bharadwaj
Download E-Certificate: Download
Author Reg. ID:
IJRTI_181341
Published Paper Id: IJRTI2009002
Published In: Volume 5 Issue 9, September-2020
DOI:
Abstract: The LC method for the determination of test procedures of Assay for Amlodipine Besylate and Telmisartan HCl in bulk drug, and tablets were simple, reliable, sensitive and less time consuming. The positivity of the present working procedures was a simple isocratic method. The present method can be used for rapid and precise quantification of Amlodipine Besylate and Telmisartan HCl. The present work showing a validation with highly sensitive and selective method for the estimation of Amlodipine Besylate and Telmisartan HCl in pharmaceutical dosage forms.
Keywords: HPLC, Amlodipine Besylate, Telmisartan HCl , Chromatogram , Validation .
Cite Article: "A Validated Rp-Hplc Method for Tablets Containing Amlodipine Besylate and Telmisartan Hcl as Active Pharmaceutical Ingredient.", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.5, Issue 9, page no.7 - 22, September-2020, Available :http://www.ijrti.org/papers/IJRTI2009002.pdf
Downloads: 000102306
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2009002
Registration ID:181341
Published In: Volume 5 Issue 9, September-2020
DOI (Digital Object Identifier):
Page No: 7 - 22
Country: HYDERABAD, TELANGANA, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2009002
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2009002
Share Article:

Share Facebook Twitter Google+ Pinterest LinkedIn Email Tumblr WhatsApp Google Gmail

Click Here to Download This Article

Article Preview
Click Here to Download This Article
Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Join RMS/Earn 300
IJRTI

Indexing Partner
Copyright © 2022 - All Rights Reserved - IJRTI